Immuneering Class A financial statements

이뮤니어링NASDAQ:IMRX · Nasdaq · Healthcare · sector #13
$4.04-0.74%
2026-10-05 close

Immuneering Class A's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$64M.

Reported results

Immuneering Class A notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q